World Tuberculosis Day, marked each year on 24 March, is an occasion to raise awareness and advocate for efforts to eliminate TB. It is high time to end TB.
The latest ECDC/WHO report Tuberculosis surveillance and monitoring in Europe 2019 (2017 data) shows that despite an overall decline in numbers of people suffering from TB, the disease remains a major public health challenge in the Region.
It should be. Despite being a curable disease, tuberculosis (TB) is still a challenging public health issue in the European Union and European Economic Area (EU/EEA), with over 55 000 TB infections reported annually and thousands of fatalities.
On 28 January, Public Health England (PHE) launched a new multilingual survey, funded by the European Centre for Disease Prevention and Control (ECDC), which aims to gain an understanding of European healthcare workers’ knowledge and attitudes about antibiotics and antibiotic resistance.
On European Antibiotic Awareness Day, ECDC publishes the results of two point-prevalence surveys of healthcare-associated infections and antimicrobial use in hospitals and in long-term care facilities in the EU/EEA.
The European Centre for Disease Prevention and Control (ECDC) has published comprehensive guidance on the management of latent tuberculosis infection (LTBI) targeted for European Union/European Economic Area (EU/EEA) countries.
The European Centre for Disease Prevention and Control (ECDC) and the European Respiratory Society (ERS) have developed 21 patient-centred standards to guide clinicians and public health workers in their work to ensure optimal diagnosis, treatment and prevention of tuberculosis (TB) in Europe.
People in prison experience a higher burden of communicable diseases such as hepatitis B (HBV), hepatitis C (HCV) and HIV often linked to a history of injecting drug use.